✦ LIBER ✦

Evaluation of the safety and efficacy of once-weekly PEG/interferon alfa-2A (PEGASYS™) for chronic hepatitis C. A multinational, randomized study

✍ Scribed by S. Zeuzem; S.V. Feinman; J. Rasenack; E.J. Heathcote; M.-Y. Lai; E. Gane; J. O'Grady; J. Reichen; M.J. Brunda

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated (40 KDA) interferon alfa-2a (P

✍ A.M. Di Bisceglie; D.E. Bernstein; V.R. Rustgi; N. Gitlin; L.J. Jeffers; D. Simo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Efficacy, safety, and tolerability in pa

✍ Perrillo, Robert P.; Rothstein, Kenneth D.; Alam, Imtiaz; Thuluvath, Paul J.; Pa 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Efficacy and safety of interferon alfa-2

✍ Petr Husa; Vladislav Krtek; Jiri Svejda; Jaroslav Stransky; Blanka Cieslarova; V 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Efficacy, quality of life, safety, and t

✍ Kenneth D. Rothstein; Robert P. Perrillo; Joanne Imperial; Imtiaz Alam; Melissa 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Comparison between combination therapy w

✍ M. Capanni; M.R. Biagini; S. Nanni; E. Lorefice; M. Paci; M.C. Benini; E. Gai; A 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 111 KB

PIN31: THE COST-EFFECTIVENESS OF PEGINTE

✍ SD Sullivan; J Green; KK Patel; A Craxi; A Alberti; G Giuliani; C De Carli 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB